Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 4 days ago

Medpace Holdings, Inc.: AQR CAPITAL MANAGEMENT LLC discloses a stake of more than 5% (Schedule 13G)

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 13 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

AQR Capital Management LLC disclosed a stake exceeding 5% in Medpace Holdings, Inc. via a Schedule 13G filing with the SEC (accession 0001167557-26-000279). The passive-investment disclosure signals the quantitative asset manager has built a meaningful position in the clinical research organization. The exact share count and percentage were not specified in the filing headline. Investors will watch for further 13G amendments or 13D filings that could indicate a shift from passive to activist intent.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Medpace Holdings, Inc., AQR Capital Management LLC